Psyence Biomedical Ltd. (PBM)

4.20 -0.13 (-3.00%) USD  |  NASDAQ  |  Aug 24, 16:00
4.20 0.00 (0.00%) After-Hours: 20:00
More

Psyence Biomedical EPS Diluted (Quarterly) : -3.178 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for PBM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
September 30, 2025 -3.178
September 30, 2024 0.0426
September 30, 2023 -6.314
June 30, 2023 -0.0078
March 31, 2023 -0.0021
December 31, 2022 0.0689
September 30, 2022 0.0269
Date Value
June 30, 2022 5.374
March 31, 2022 7.760
December 31, 2021 19.07
September 30, 2021 -0.1035
June 30, 2021 -0.063
March 31, 2021 -0.0158

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Sirona Biochem Corp. --
Xenon Pharmaceuticals, Inc. -1.112
Aurinia Pharmaceuticals, Inc. 0.2802
enGene Therapeutics, Inc. -0.4335
Medicus Pharma Ltd. -0.1524

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -0.7533M
Total Expenses (Quarterly) 0.7533M